Acadia Healthcare Company, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Acadia Healthcare Company, Inc. on July 2, 2015. The filing serves to provide audited historical financial statements for CRC Health Group, Inc. ("CRC"), which Acadia acquired on February 11, 2015. The financial data presented covers the fiscal year ended December 31, 2014, and was audited by Deloitte & Touche LLP to comply with Regulation S-X Rule 3-10(g).
Key Financial Metrics
The filing text references the inclusion of audited financial statements for CRC, including the Consolidated Balance Sheet, Statement of Operations, Statement of Comprehensive Loss, Statement of Changes in Equity, and Statement of Cash Flows for the year ended December 31, 2014. However, the specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity are not provided in the text of this summary report; they are contained within the attached Exhibit 99.
Material Changes
The primary material event referenced is the completion of the acquisition of CRC Health Group, Inc. on February 11, 2015. This filing represents a regulatory compliance step to disclose the historical financials of the acquired entity rather than reporting operational changes for the current period.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, or specific risk factors related to future operations. The document is strictly a procedural filing to attach audited financial statements and the consent of the independent registered public accounting firm.
Investor Verification Checklist
- Review Exhibit 99 for the specific audited financial figures of CRC Health Group, Inc. for the year ended December 31, 2014.
- Verify the audit opinion issued by Deloitte & Touche LLP included in the report.
- Confirm the integration status of CRC into Acadia's consolidated financials in subsequent quarterly reports.
- Check for any subsequent filings regarding the final purchase price allocation of the CRC acquisition.